Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-07

FDA Approved: FOSTER AND THRIVE ALLERGY AND CONGESTION D — Original Application (Strategic Sourcing Services LLC)

View source ↗

Summary

FDA approved a generic fixed-dose combination product Foster and Thrive Allergy and Congestion D containing fexofenadine hydrochloride and pseudoephedrine hydro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSTER AND THRIVE ALLERGY AND CONGESTION D (Fexofenadine hydrochloride, pseudoephedrine hydrochloride)

Snippet

ORIG AP for FOSTER AND THRIVE ALLERGY AND CONGESTION D (FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE)